Identity What this record covers
A peptide commonly associated with thymosin beta-4 discussions and recovery claims, where evidence must be separated by exact molecule and model.
Aliases: Thymosin beta-4 fragment, TB500
Topics: mobility, peptide, recovery, tissue repair
Formula: C38H68N10O14
Sequence: Ac-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln
Regulatory/product note: Separate approved-product evidence, research evidence, and supplier product claims.
Mechanism Proposed mechanism
Often discussed around actin binding, cell migration, inflammation models, and tissue-remodeling hypotheses.
Evidence Evidence map boundary
This record keeps mechanisms, animal studies, human biomarkers, controlled clinical outcomes, safety data, and supplier documentation separate so claims are not flattened into one misleading score.
Research questions tracked
- What exact molecule, route, formulation, and outcome were studied?
- Is the evidence mechanistic, animal, early human, or controlled clinical evidence?
- Does the commercial product match the studied material and documentation?
Key findings and boundaries
- Evidence strength changes by outcome and study type.
- Mechanism is useful context but not proof of clinical benefit.
- Supplier claims require separate documentation review.
Important gaps
- Long-term human safety and real-world product quality are often incomplete.
- Claims can exceed the route, formulation, and population studied.
Safety Safety and unknowns
Public products and research discussions may not refer to identical material. Documentation and exact identity matter.
- Known and plausible adverse effects must be separated from product-quality risks.
- Injectable or research-use products add sterility, endotoxin, impurity, and handling concerns.
Testing & COAs Documentation checklist
COAs can support identity, purity, assay, batch traceability, laboratory identity, and testing date review. They do not prove clinical effectiveness, legal status, storage integrity, sterility unless tested, or suitability for use.
- Identity, assay/purity, batch matching, lab identity, and test date should be visible.
- COAs do not prove clinical effectiveness, legal status, or suitability for use.
Sources Primary references and official context